These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24617352)
1. Evaluation of platelet response to different clopidogrel dosing regimens in patients with acute coronary syndrome in clinical practice. Fefer P; Beigel R; Rosenberg N; Shechter M; Gannot S; Varon D; Savion N; Hod H; Matetzky S Platelets; 2015; 26(2):127-31. PubMed ID: 24617352 [TBL] [Abstract][Full Text] [Related]
2. High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel. Geisler T; Booth J; Tavlaki E; Karathanos A; Müller K; Droppa M; Gawaz M; Yanez-Lopez M; Davidson SJ; Stables RH; Banya W; Zaman A; Flather M; Dalby M PLoS One; 2015; 10(8):e0135037. PubMed ID: 26317618 [TBL] [Abstract][Full Text] [Related]
3. The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment. Kalantzi KI; Dimitriou AA; Goudevenos JA; Tselepis AD Platelets; 2012; 23(2):121-31. PubMed ID: 21806493 [TBL] [Abstract][Full Text] [Related]
4. Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study. Montalescot G; Sideris G; Cohen R; Meuleman C; Bal dit Sollier C; Barthélémy O; Henry P; Lim P; Beygui F; Collet JP; Marshall D; Luo J; Petitjean H; Drouet L Thromb Haemost; 2010 Jan; 103(1):213-23. PubMed ID: 20062936 [TBL] [Abstract][Full Text] [Related]
5. Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome. Cuisset T; Quilici J; Grosdidier C; Fourcade L; Gaborit B; Pankert M; Molines L; Morange PE; Bonnet JL; Alessi MC Am J Cardiol; 2011 Nov; 108(10):1411-6. PubMed ID: 21872198 [TBL] [Abstract][Full Text] [Related]
6. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Carvajal J; Lehmann A; Lambert M; Bonnet JL; Alessi MC J Am Coll Cardiol; 2006 Oct; 48(7):1339-45. PubMed ID: 17010792 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial. Yong G; Rankin J; Ferguson L; Thom J; French J; Brieger D; Chew DP; Dick R; Eccleston D; Hockings B; Walters D; Whelan A; Eikelboom JW Am Heart J; 2009 Jan; 157(1):60.e1-9. PubMed ID: 19081397 [TBL] [Abstract][Full Text] [Related]
8. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy. Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395 [TBL] [Abstract][Full Text] [Related]
9. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study. Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149 [TBL] [Abstract][Full Text] [Related]
10. The relationship between on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes in Chinese patients. Tang N; Yin S; Sun Z; Xu X; Qin J Scand J Clin Lab Invest; 2015 May; 75(3):223-9. PubMed ID: 25594796 [TBL] [Abstract][Full Text] [Related]
11. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy. Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. Storey RF; Angiolillo DJ; Patil SB; Desai B; Ecob R; Husted S; Emanuelsson H; Cannon CP; Becker RC; Wallentin L J Am Coll Cardiol; 2010 Oct; 56(18):1456-62. PubMed ID: 20832963 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251 [TBL] [Abstract][Full Text] [Related]
14. Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study. Valenti R; Marcucci R; Capodanno D; De Luca G; Migliorini A; Gori AM; Parodi G; Giusti B; Carrabba N; Paniccia R; Cantini G; Marrani M; Gensini GF; Abbate R; Antoniucci D J Thromb Thrombolysis; 2015 Jul; 40(1):76-82. PubMed ID: 25502874 [TBL] [Abstract][Full Text] [Related]
15. Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy. Cuisset T; Gaborit B; Dubois N; Quilici J; Loosveld M; Beguin S; Loundou AD; Moro PJ; Morange PE; Alessi MC; Dutour A; Bonnet JL Int J Cardiol; 2013 Sep; 168(1):523-8. PubMed ID: 23084816 [TBL] [Abstract][Full Text] [Related]
16. Prasugrel overcomes high on-clopidogrel platelet reactivity in the acute phase of acute coronary syndrome and maintains its antiplatelet potency at 30-day follow-up. Koziński M; Obońska K; Stankowska K; Navarese EP; Fabiszak T; Stolarek W; Kasprzak M; Siller-Matula JM; Rość D; Kubica J; De Servi S Cardiol J; 2014; 21(5):547-56. PubMed ID: 24671900 [TBL] [Abstract][Full Text] [Related]
17. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250 [TBL] [Abstract][Full Text] [Related]
18. Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy. Tsoumani ME; Tatsidou PT; Ntalas IV; Goudevenos JA; Tselepis AD Platelets; 2016 Dec; 27(8):812-820. PubMed ID: 27337147 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction. Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506 [TBL] [Abstract][Full Text] [Related]
20. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Fox KA; Granger CB; Jolly S; Rupprecht HJ; Widimsky P; Yusuf S; Am Heart J; 2008 Dec; 156(6):1080-1088.e1. PubMed ID: 19033002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]